This inventor holds 1 USPTO granted patent and 2 published patent applications and 3 EPO patents. Top assignee: Cellectis S.a.. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Christoph Leder: Innovator in Prostate Cancer Vaccine Development
Introduction
Christoph Leder is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medical research, particularly in the development of vaccines. His innovative work focuses on creating methods and compositions for a vaccine against prostate cancer.
Latest Patents
Leder holds a patent for "Methods and compositions relating to a vaccine against prostate cancer." This invention aims to provide methods and compositions that include a non-human primate PSA for administration to humans. The goal is to elicit an immune response against human PSA. More broadly, the invention seeks to utilize a non-human primate xenogeneic antigen in humans, ensuring minimal interspecies differences to optimize the immune response to the human's native self-antigen. He has 1 patent in this area.
Career Highlights
Throughout his career, Christoph Leder has worked with prominent companies in the biotechnology sector. Notable among these are Cellectis S.A. and Medtron AG. His experience in these organizations has contributed to his expertise in vaccine development and immunology.
Collaborations
Leder has collaborated with esteemed colleagues, including Alan D. King and Maxim Pavlenko. These partnerships have further enriched his research and innovation in the field of cancer vaccines.
Conclusion
Christoph Leder's work in developing a vaccine against prostate cancer showcases his commitment to advancing medical science. His innovative approaches and collaborations highlight the importance of research in combating serious health issues.